Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2016-02-29
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The PROspective German NOn-CF bronchiectaSIS Patient Registry
NCT02574143
Long-Term Study On Home Spirometry After Lung Transplantation
NCT00743171
Hospitalary Chronic Obstructive Pulmonary Disease Registry
NCT02659189
Demonstration of Broncholytic Effects in Subjects With Obstructive Airway Diseases by Low Frequency Ultrasound
NCT01080924
Respiratory Registry for Lung Health: a Prospective, Observational Study on Adult Patients With Asthma or COPD
NCT05826613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore a routine flexible bronchoscopy is carried out, whereat the choice of analgosedation medication is for the investigators decision, independent from the study.
Subsequently the following data are collected:
* duration of medical examination
* medication (e.g. midazolam, fentanyl, propofol, lidocain)
* vital signs at the end of the examination
* complications
Furthermore the patient should be asked concerning the general tolerance for the procedure and different symptoms like emesis, feeling of suffocation, cough and pain (0 = no stress, 100 = intolerable). In addition to that the grade of amnesia and the acceptance for later bronchoscopies should be asked.
Analyzing this data will optimize the internal quality control concerning the conducted examination, collect all complications related to the analgosedation and enhance the patients comfort during a flexible bronchoscopy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Indication for a flexible bronchoscopy
Patients representing to the hospital with the indication for a flexible bronchoscopy
Indication for a flexible bronchoscopy
The data of patients are collected within the hospital routine documentation during the flexible bronchoscopy. The bronchoscopy is performed regardless of this study. Following the bronchoscopy the patients are asked a few questions about their health and their perception.
The follow-up of all patients is done via phone calls in order to collect data about the outcome of each patient.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indication for a flexible bronchoscopy
The data of patients are collected within the hospital routine documentation during the flexible bronchoscopy. The bronchoscopy is performed regardless of this study. Following the bronchoscopy the patients are asked a few questions about their health and their perception.
The follow-up of all patients is done via phone calls in order to collect data about the outcome of each patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with the medical indication for a flexible bronchoscopy
* Pregnant or breastfeeding women
* Participation in other studies
* Sponsor-dependent patients or patients who are working with the sponsor
* Patients without mental ability or capacity to understand and follow the instructions of the investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Dreher, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
RWTH Aachen University Hospital, MK1
Tobias Müller, PD
Role: PRINCIPAL_INVESTIGATOR
RWTH Aachen University Hospital, MK1
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Aachen, Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine
Aachen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.